Air Liquide Plans Sale of Its Stake in Anios
October 09 2013 - 2:30AM
Business Wire
Regulatory News:
Air Liquide (Paris:AI) announces it plans to sell its stake in
Laboratoires Anios, a company that specializes in disinfectant and
antiseptic products, in order to refocus the development of its
hygiene business on Schülke, a company it wholly owns.
In connection with this planned sale, Air Liquide also indicates
that it has received a firm offer from a consortium composed of the
Letartre family, founder of Laboratoires Anios and currently a
minority shareholder, and the investment firm Ardian (formerly AXA
Private Equity).
Air Liquide will respond to this offer at the end of the
instruction and consultation process with relevant trade union
representatives of personnel affected by the sale. In addition, the
transaction will be subject to the approval of the French
competition authority.
***
Founded in 1898, Laboratoires Anios has a staff of about 450
employees and generated revenues of around 180 million euros in
2012.
Air Liquide is the world leader in gases for industry, health
and the environment, and is present in 80 countries
with close to 50,000 employees. Oxygen, nitrogen,
hydrogen and rare gases have been at the core of Air Liquide’s
activities since its creation in 1902. Using these molecules, Air
Liquide continuously reinvents its business, anticipating the needs
of current and future markets. The Group innovates for the good of
society while delivering profitable growth and consistent
performance.
Innovative technologies that curb polluting emissions,
lower industry’s energy use, recover and reuse natural resources or
develop the energies of tomorrow, such as hydrogen, biofuels or
photovoltaic energy… Oxygen for hospitals, home healthcare,
fighting nosocomial infections… Air Liquide combines many products
and technologies to develop valuable applications and services not
only for its customers but also for society.
A partner for the long term, Air Liquide relies on
employee commitment, customer trust and shareholder support to
pursue its vision of sustainable, competitive growth. The
diversity of Air Liquide’s teams, businesses, markets and
geographic presence provides a solid and sustainable base for its
development and strengthens its ability to push back its own
limits, conquer new territories and build its future.
Air Liquide explores the best that air can offer to preserve
life, staying true to its Corporate Social Responsibility and
sustainable development approach. In 2012, the Group’s revenues
amounted to € 15.3 billion of which 82% were
generated outside France. Air Liquide is listed on the Paris
Euronext stock exchange (compartment A) and is a member of the CAC
40 and Dow Jones Euro Stoxx 50 indexes.
Air Liquide Healthcare
Air Liquide Healthcare supplies medical gases, home
healthcare services, hygiene products, medical equipment and
specialty ingredients.
In 2012, it served over 7,500 hospitals and 1
million patients at home throughout the world.
The Group’s Healthcare business reached €
2,482 million in revenues in 2012, with the support
of its 10 000 employees.
Schülke
Schülke is a hygiene specialist, developing and selling
disinfectant, antiseptic and cleaning products, with a
particular focus on hospitals and doctor’s offices, and industrial
preservatives. Founded in Germany in 1889, the company was
acquired by Air Liquide in 1996.
Schülke has approximately 700 employees and its revenues
totaled close to 200 million euros in 2012, 60% generated
abroad.
www.airliquide.comFollow us on
Twitter @AirLiquideGroup
Air LiquideCorporate CommunicationsAnne Bardot, + 33 (0)1
40 62 53 34orAnette Rey, + 33 (0)1 40 62 51 31orInvestor
RelationsVirginia Jeanson, +33 (0) 1 40 62 57 37orAnnie Fournier,
+33 (0) 1 40 62 57 18
C3 AI (NYSE:AI)
Historical Stock Chart
From Sep 2024 to Oct 2024
C3 AI (NYSE:AI)
Historical Stock Chart
From Oct 2023 to Oct 2024